TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18295276

Group type: EXPERIMENTAL
Intervention: Urodynamic stress incontinence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detrusor overactivity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valsalva leak point pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Burch or pubovaginal sling procedure
Number of subjects: 0
Study: 16893754

Group type: EXPERIMENTAL
Intervention: Isolated coronary artery bypass grafting (CABG) in patients with OSAS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Matched control group (65 patients)
Number of subjects: 20
Study: 12824833

Group type: EXPERIMENTAL
Intervention: Heavy silicone oil-RMN3 mixture (heavy silicone oil)
Number of subjects: 33
Study: 11426582

Group type: EXPERIMENTAL
Intervention: Pravastatin (10‐20 mg/day)
Number of subjects: 5610

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 5610
Study: 8693317

Group type: EXPERIMENTAL
Intervention: Prehospitalization phase intervention
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Hospital intervention (door to needle time lapse)
Number of subjects: 570
Study: 1900384

Group type: EXPERIMENTAL
Intervention: Lower linoleic acid diet (3.8 en%)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Higher linoleic acid diet (10.8 en%)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 11
Study: 6829485

Group type: EXPERIMENTAL
Intervention: 15 mg Zn daily supplement (group B)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No Zn supplement (group A)
Number of subjects: 46
Study: 31797522

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg
Number of subjects: 161

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 161
Study: 31005386

Group type: COMPARATOR
Intervention: Phenytoin (20 mg/kg intravenous or intraosseous infusion over 20 min)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Levetiracetam (40 mg/kg intravenous or intraosseous infusion over 5 min)
Number of subjects: 233
Study: 27998036

Group type: EXPERIMENTAL
Intervention: Synovitis
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Extent of medial synovitis
Number of subjects: 107
Study: 25711400

Group type: EXPERIMENTAL
Intervention: Intralesional collagenase Clostridium histolyticum (CCH)
Number of subjects: 492

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 492
Study: 24357642

Group type: COMPARATOR
Intervention: Neutral shoe (Nike Pegasus 28)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Partial minimalist shoe (Nike Free 3.0 V2)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Full minimalist shoe (Vibram 5‐Finger Bikila)
Number of subjects: 103
Study: 22289234

Group type: EXPERIMENTAL
Intervention: Supervised WBV training (2 sessions/week for 6 weeks; 12 repetitions of 40-60s WBV per session)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo vibrating platform (0.2mm amplitude)
Number of subjects: 31
Study: 19249015

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control Interview (CI)
Number of subjects: 81
Study: 17479824

Group type: EXPERIMENTAL
Intervention: Child care center staff intervention
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 298
Study: 15281492

Group type: EXPERIMENTAL
Intervention: 1 unit of allogeneic RBCs (transfusion 1; n = 17)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 2 units of allogeneic RBCs (transfusion 2; n = 17)
Number of subjects: 51

Group type: COMPARATOR
Intervention: 100% oxygen ventilation (n = 17)
Number of subjects: 51
Study: 11340315

Group type: EXPERIMENTAL
Intervention: Foot Reflex Zone Massage (FRZM) therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo group (massage on zones unrelated to the intestines)
Number of subjects: 32
Study: 9389899

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (100 mg dl-alpha-tocopheryl acetate daily for 3 months)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 74
Study: 8184351

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS/CODETRON) with exercise regimen
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo stimulation with exercise regimen
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 58
Study: 3115833

Group type: EXPERIMENTAL
Intervention: Subcutaneous leuprolide (500 micrograms/day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intranasal leuprolide (1600 micrograms/day)
Number of subjects: 14
Study: 28964904

Group type: EXPERIMENTAL
Intervention: Self-reported hunger
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Self-reported thirst
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Other constructs (hunger, fullness, emptiness, appetite)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Covariates in fMRI models
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Subjective self-reported hunger, satiety and related constructs
Number of subjects: 32
Study: 27706483

Group type: EXPERIMENTAL
Intervention: Micafungin (100 mg, once daily, for 14 days)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Micafungin
Number of subjects: 260
Study: 25569053

Group type: EXPERIMENTAL
Intervention: Subcutaneous suture
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control (no subcutaneous suture)
Number of subjects: 180
Study: 23678038

Group type: EXPERIMENTAL
Intervention: Oral 17β-estradiol (E₂) at a mean dose of 2 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transdermal 17β-estradiol (E₂) at a mean dose of 0.1 mg
Number of subjects: 40
Study: 20519423

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 mL (50 microg) added to local anesthetics
Number of subjects: 77

Group type: COMPARATOR
Intervention: Saline placebo 1 mL
Number of subjects: 77
Study: 17983881

Group type: EXPERIMENTAL
Intervention: Bulky dressing removed at 24 hours
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bulky dressing removed at 2 weeks
Number of subjects: 100
Study: 16365322

Group type: EXPERIMENTAL
Intervention: True intervention group (n = 18)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham control group (n = 20)
Number of subjects: 38
Study: 14669194

Group type: EXPERIMENTAL
Intervention: High-frequency vibration training (28Hz) for three 2-minute sessions, twice weekly for 6 months
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High-frequency vibration training (28Hz)
Number of subjects: 29
Study: 10974208

Group type: EXPERIMENTAL
Intervention: CDP‐choline (citicoline; 500 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CDP‐choline (citicoline; 2000 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CDP‐choline (citicoline; 4000 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9058178

Group type: EXPERIMENTAL
Intervention: Experimental group (N = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (N = 8)
Number of subjects: 16
Study: 8396833

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 6 mg
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 12 mg
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 3520601

Group type: COMPARATOR
Intervention: 200 mg clotrimazole vaginal tablets once daily for 3 consecutive days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 80 mg terconazole vaginal tablets once daily for 3 consecutive days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: one 240 mg terconazole vaginal tablet followed by 2 identical placebo pessaries
Number of subjects: 60
Study: 30927498

Group type: EXPERIMENTAL
Intervention: CXP (novel resorbable non‐cross‐linked collagen membrane)
Number of subjects: 49

Group type: COMPARATOR
Intervention: BG (non‐cross‐linked resorbable membrane)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CXP
Number of subjects: 49

Group type: COMPARATOR
Intervention: BG
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CXP and BG
Number of subjects: 49
Study: 28387895

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg/die)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional therapy (Control)
Number of subjects: 56
Study: 25940902

Group type: EXPERIMENTAL
Intervention: Heterozygous TPMT*1/*3A
Number of subjects: 2387

Group type: EXPERIMENTAL
Intervention: Homozygous wild-type TPMT*1/*1
Number of subjects: 2387

Group type: EXPERIMENTAL
Intervention: Heterozygous TPMT*1/*3C
Number of subjects: 2387

Group type: EXPERIMENTAL
Intervention: High-risk MRD patients
Number of subjects: 2387
Study: 23704994

Group type: EXPERIMENTAL
Intervention: Eplerenone (25-50 mg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard medication (control)
Number of subjects: 54
Study: 22470245

Group type: EXPERIMENTAL
Intervention: 1 mg Ondansetron
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 4 mg Ondansetron
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 8 mg Ondansetron
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 1 mg and 8 mg Ondansetron
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 19321717

Group type: EXPERIMENTAL
Intervention: Social skills group intervention program (8 sessions, 2 hours each)
Number of subjects: 32
Study: 17286787

Group type: EXPERIMENTAL
Intervention: Quazepam 20 mg with light food
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg with light food
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg with light food
Number of subjects: 21
Study: 15128344

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (omeprazole 20 mg or esomeprazole 40 mg daily)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Antacid (aluminum hydroxide 800 mg daily)
Number of subjects: 72
Study: 11435263

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER 37.5 mg/day
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER 75 mg/day
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER 150 mg/day
Number of subjects: 541

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 541
Study: 9728580

Group type: EXPERIMENTAL
Intervention: Single-agent gemcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin/etoposide
Number of subjects: 0
Study: 11271178

Group type: EXPERIMENTAL
Intervention: FK506
Number of subjects: 545

Group type: COMPARATOR
Intervention: CBIR
Number of subjects: 545
Study: 3142635

Group type: EXPERIMENTAL
Intervention: 1% noxythiolin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 100
Study: 8174979

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg twice daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 102674

Group type: EXPERIMENTAL
Intervention: Chewable fluoride tablets (1 mg of fluoride) once a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chewable fluoride tablets (1 mg of fluoride) twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablet once a day
Number of subjects: 0
Study: 31857570

Group type: EXPERIMENTAL
Intervention: Barbed suture group
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Common suture group
Number of subjects: 189

Group type: COMPARATOR
Intervention: T‐tube drainage (TTD) group
Number of subjects: 189
Study: 28257916

Group type: EXPERIMENTAL
Intervention: Listening to music during UDS
Number of subjects: 148

Group type: COMPARATOR
Intervention: No music during UDS
Number of subjects: 148
Study: 24812035

Group type: EXPERIMENTAL
Intervention: Effective stimulation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Subthreshold stimulation
Number of subjects: 8

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 8
Study: 23463857

Group type: EXPERIMENTAL
Intervention: SCN5A variant rs1805126
Number of subjects: 5272

Group type: EXPERIMENTAL
Intervention: SCN10A variant rs6795970
Number of subjects: 5272

Group type: EXPERIMENTAL
Intervention: SCN10A and SCN5A variants
Number of subjects: 5272

Group type: EXPERIMENTAL
Intervention: SCN10A variants
Number of subjects: 5272
Study: 21291432

Group type: EXPERIMENTAL
Intervention: New Hope program
Number of subjects: 866

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 866
Study: 19013590

Group type: EXPERIMENTAL
Intervention: Alfuzosin
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 16895262

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (6 g nightly for 4 weeks, then increased to 9 g nightly for 4 additional weeks)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Sodium oxybate plus modafinil
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Sodium oxybate
Number of subjects: 270

Group type: COMPARATOR
Intervention: Modafinil (placebo)
Number of subjects: 270
Study: 14718290

Group type: EXPERIMENTAL
Intervention: African American participants
Number of subjects: 439

Group type: COMPARATOR
Intervention: Other participants
Number of subjects: 439
Study: 11911512

Group type: EXPERIMENTAL
Intervention: One-point cane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Four-point cane
Number of subjects: 30

Group type: COMPARATOR
Intervention: No cane
Number of subjects: 30
Study: 9822507

Group type: EXPERIMENTAL
Intervention: Intramuscular dexamethasone (6 mg every 12 hours for a total of 4 doses)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral dexamethasone (8 mg every 12 hours for a total of 4 doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 24
Study: 8126916

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusions of epirubicin (Group B)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Intravenous epirubicin (Group C)
Number of subjects: 73

Group type: COMPARATOR
Intervention: No neoadjuvant therapy (Group A)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 73
Study: 2536462

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (mitomycin C 10 mg/m2, vinblastine 5 mg/m2, methotrexate 40 mg/m2, cisplatin 40 mg/m2 every 28 days)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Sequential single-agent chemotherapy (mitomycin C 10 mg/m2 monthly until progression, vinblastine 5 mg/m2 every 2 weeks until progression, methotrexate 40 mg/m2 weekly until relapse)
Number of subjects: 105
Study: 4913786

Group type: EXPERIMENTAL
Intervention: Oral prethcamide (200 mg, four times daily)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oral prethcamide
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31177232

Group type: EXPERIMENTAL
Intervention: Preferred music listening group intervention (60 minutes, 5 days/week for 8 weeks)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 119
Study: 28601264

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula
Number of subjects: 128

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 128
Study: 25980660

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen therapy (50 L/min, FiO2 50%)
Number of subjects: 830

Group type: COMPARATOR
Intervention: BiPAP (pressure support level 8 cm H2O, PEEP 4 cm H2O, FiO2 50%)
Number of subjects: 830

Group type: COMPARATOR
Intervention: BiPAP
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen therapy
Number of subjects: 830
Study: 23414742

Group type: EXPERIMENTAL
Intervention: High coronary artery calcium (CAC)
Number of subjects: 4074

Group type: EXPERIMENTAL
Intervention: Mobility limitation
Number of subjects: 4074

Group type: EXPERIMENTAL
Intervention: Slow gait
Number of subjects: 4074

Group type: EXPERIMENTAL
Intervention: Joint effect of high CAC and slow gait
Number of subjects: 4074
Study: 20844886

Group type: EXPERIMENTAL
Intervention: Suturing (group A, n = 23)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Electrocoagulation (group B, n = 22)
Number of subjects: 45
Study: 18518888

Group type: EXPERIMENTAL
Intervention: Subcutaneous sweat gland suction curettage (SSGSC)
Number of subjects: 28
Study: 16597081

Group type: EXPERIMENTAL
Intervention: Desloratadine, 5 mg once daily
Number of subjects: 1179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1179
Study: 12560306

Group type: EXPERIMENTAL
Intervention: Lidocaine 0.5% (L)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lidocaine 0.5% plus sufentanil 0.75 microg (L+S)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sufentanil 0.75 microg (S)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Reference (REF)
Number of subjects: 9
Study: 11487604

Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9496344

Group type: EXPERIMENTAL
Intervention: Glutamine (1 mM)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control (glucose-free medium without glutamine)
Number of subjects: 138
Study: 7993600

Group type: EXPERIMENTAL
Intervention: Cheese compounds and saliva due to masticating 20 gm hard cheese for 5 minutes
Number of subjects: 8

Group type: COMPARATOR
Intervention: Stimulated saliva
Number of subjects: 8

Group type: COMPARATOR
Intervention: Non-irradiated subjects
Number of subjects: 8
Study: 2543596

Group type: EXPERIMENTAL
Intervention: sodium cromoglycate (SCG) (7.3 +/- 0.6 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: nedocromil sodium (NED) (7.5 +/- 0.6 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Comparison between SCG and NED
Number of subjects: 11
Study: 17896753

Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 31530667

Group type: EXPERIMENTAL
Intervention: Oral semaglutide 3 mg
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Oral semaglutide 7 mg
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Oral semaglutide 14 mg
Number of subjects: 731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 731
Study: 29544571

Group type: EXPERIMENTAL
Intervention: Intravenous continuous infusion of tranexamic acid (TXA) at 5 mg/kg/hour
Number of subjects: 60

Group type: COMPARATOR
Intervention: Three intravenous boluses of tranexamic acid (TXA) at 10 mg/kg after induction, after going to bypass and after protamine reversal
Number of subjects: 60
Study: 26306891

Group type: EXPERIMENTAL
Intervention: Positive test only
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Positive test with specificity and sensitivity
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Positive test with positive likelihood ratio in layman terms
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Overall understanding of diagnostic accuracy parameters
Number of subjects: 326
Study: 24785954

Group type: EXPERIMENTAL
Intervention: Haplogroup B patients
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Haplogroup B
Number of subjects: 118

Group type: COMPARATOR
Intervention: Older age, higher baseline CD4 cell count, higher complex I level, and higher ENFD at baseline
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: HIV‐SN cases
Number of subjects: 118
Study: 22528620

Group type: EXPERIMENTAL
Intervention: PEMs from MedlinePlus
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: PEMs from EBSCO
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: PEMs from Micromedex
Number of subjects: 300
Study: 19157617

Group type: EXPERIMENTAL
Intervention: Home-based resistance training using exercise bands
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17186305

Group type: EXPERIMENTAL
Intervention: Bedrest
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study: 15138837

Group type: EXPERIMENTAL
Intervention: ACE gene insertion (I) allele
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ACE gene deletion (D) allele
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Genotype frequencies (II versus ID versus DD)
Number of subjects: 35
Study: 12474070

Group type: EXPERIMENTAL
Intervention: 500 ml of red wine (12 % ethanol)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 12 % ethanol dilution
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dealcoholized red wine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Red grape juice
Number of subjects: 6
Study: 10434214

Group type: EXPERIMENTAL
Intervention: Nellcor Symphony N‐3000 with Oxismart signal processing technique
Number of subjects: 603

Group type: COMPARATOR
Intervention: Conventional pulse oximeter (Criticare 504) with averaging time set at 12 seconds
Number of subjects: 603

Group type: COMPARATOR
Intervention: Conventional pulse oximeter (Criticare 504) with averaging time set at 21 seconds
Number of subjects: 603
Study: 7606610

Group type: EXPERIMENTAL
Intervention: Topical bacitracin zinc (BAC)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Neomycin sulfate, bacitracin zinc, and polymyxin B sulfate combination (NEO)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine (SIL)
Number of subjects: 426

Group type: COMPARATOR
Intervention: Petrolatum (PTR)
Number of subjects: 426
Study: 2141773

Group type: EXPERIMENTAL
Intervention: Fentanyl (50 or 100 micrograms/kg) or Sufentanil (10, 20, or 30 micrograms/kg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sufentanil in one of four doses: 30 micrograms/kg as a single dose, 10 micrograms/kg plus infusion 0.05 microgram.kg‐1.min‐1, 20 micrograms/kg plus infusion 0.1 microgram.kg‐1.min‐1, or 40 micrograms/kg plus infusion 0.2 microgram.kg‐1.min‐1
Number of subjects: 80
Study: 91901

Group type: EXPERIMENTAL
Intervention: Care provided by specially trained nurses at the work site
Number of subjects: 457

Group type: COMPARATOR
Intervention: Care provided by family doctor
Number of subjects: 457
Study: 31679474

Group type: EXPERIMENTAL
Intervention: 10-week circuit strength training (mixed typical resistance training and power training)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No training (control)
Number of subjects: 25